Clinical Trials Directory

Trials / Conditions / Stage II Rectal Cancer AJCC v8

Stage II Rectal Cancer AJCC v8

14 registered clinical trials studyying Stage II Rectal Cancer AJCC v8 — 9 currently recruiting.

StatusTrialSponsorPhase
RecruitingZanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for
NCT07405476
Emory UniversityPhase 2
Not Yet RecruitingFamily Communications After Genetic Testing
NCT07143487
Alliance for Clinical Trials in OncologyN/A
RecruitingPapaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE
NCT06834126
City of Hope Medical CenterPhase 1
RecruitingDesigning a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Ca
NCT06746012
Ohio State University Comprehensive Cancer CenterN/A
RecruitingActive Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
NCT03594630
M.D. Anderson Cancer CenterEARLY_Phase 1
RecruitingTime-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side
NCT05722288
City of Hope Medical CenterPhase 2
Active Not RecruitingTesting the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After
NCT05610163
Alliance for Clinical Trials in OncologyPhase 2
Active Not RecruitingTherapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
NCT04929028
National Cancer Institute (NCI)Phase 2
Active Not RecruitingTesting Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer
NCT04751370
National Cancer Institute (NCI)Phase 2
RecruitingEstablishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer
NCT05081024
OHSU Knight Cancer Institute—
TerminatedTesting the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine)
NCT04406857
National Cancer Institute (NCI)Phase 1
RecruitingShort Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
NCT04703101
Jonsson Comprehensive Cancer CenterPhase 1
Active Not RecruitingFinancial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment
NCT03516942
ECOG-ACRIN Cancer Research Group—
RecruitingEvaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer
NCT02107105
M.D. Anderson Cancer Center—